CRS outcomes and disease control – Are we doing well?

.ical

09-09, 14:30–15:30 (Europe/Istanbul), Rhinology 1 (ICC - B2 level BEYAZIT)

Ahmad R. Sedaghat

<p>Ahmad Sedaghat, MD, PhD is Professor, Executive Vice Chair, Director of the Division of Rhinology, Allergy and Anterior Skull Base Surgery, Director of Clinical Research at Residency Program Director in the Department of Otolaryngology - Head and Neck Surgery at the University of Cincinnati College of Medicine.</p>

This speaker also appears in:

• How do we measure disease control in CRS (and why we need to)

David Liu

<p></p>

This speaker also appears in:

• Quality of life after skull base surgery: Are we doing well?
• Intranasal Benign Tumours
• The Principles of FESS: A Step-by-Step Guide for the Novice
• Should we reduce dosing frequency in Biologic responders: Pros and Cons?

Martin Desrosiers

<p></p>

This speaker also appears in:

• CSR Pathophysiology Update 2026

Joaquim Mullol

<p></p>

Timothy Smith

<p></p>

Özden Savaş

<p></p>

This speaker also appears in:

• The Modern Paradigm for CSF Leak Management: Diagnostic Algorithms and Surgical Techniques
• Epistaxis: An Evidence-Based Approach